Evaluation of a Droplet
Digital Polymerase Chain Reaction Format for DNA Copy Number Quantification by Pinheiro, Leonardo B. et al.
Evaluation of a Droplet Digital Polymerase Chain Reaction Format
for DNA Copy Number Quantification
Leonardo B. Pinheiro,*
,† Victoria A. Coleman,
† Christopher M. Hindson,
‡ Jan Herrmann,
†
Benjamin J. Hindson,
‡ Somanath Bhat,
† and Kerry R. Emslie
†
†National Measurement Institute, Lindfield, New South Wales, Australia
‡Bio-Rad Laboratories, Inc., Pleasanton, California, United States
* S Supporting Information
ABSTRACT: Droplet digital polymerase chain reaction (ddPCR) is a new
technology that was recently commercialized to enable the precise
quantification of target nucleic acids in a sample. ddPCR measures absolute
quantities by counting nucleic acid molecules encapsulated in discrete,
volumetrically defined, water-in-oil droplet partitions. This novel ddPCR
format offers a simple workflow capable of generating highly stable partitioning
of DNA molecules. In this study, we assessed key performance parameters of
the ddPCR system. A linear ddPCR response to DNA concentration was
obtained from 0.16% through to 99.6% saturation in a 20,000 droplet assay
corresponding to more than 4 orders of magnitude of target DNA copy
number per ddPCR. Analysis of simplex and duplex assays targeting two distinct loci in the Lambda DNA genome using the
ddPCR platform agreed, within their expanded uncertainties, with values obtained using a lower density microfluidic chamber
based digital PCR (cdPCR). A relative expanded uncertainty under 5% was achieved for copy number concentration using
ddPCR. This level of uncertainty is much lower than values typically observed for quantification of specific DNA target sequences
using currently commercially available real-time and digital cdPCR technologies.
T
he ability to quantify nucleic acids with accuracy and
precision is fundamental to many fields of basic research,
molecular diagnostic tests, and commercial processes. Although
real-time polymerase chain reaction (PCR) has found wide-
spread utility for nucleic acid quantification, it requires the
comparison of an unknown to a standard to obtain quantitative
information. Real-time PCR is an analogue measurement based
on monitoring amplification after each cycle of PCR using
fluorescence probes. The point at which the reaction fluore-
scence crosses an intensity threshold is called the cycle threshold
(Ct). As many factors can influence PCR efficiency and hence the
Ct value, the accuracy and precision of real-time PCR can vary
widely.
The principle of digital PCR was first introduced in the
1990s
1,2 and is increasingly being utilized for quantification of
DNA targets.
3−5 Digital PCR is an end-point measurement that
provides the ability to quantify nucleic acids without the use of
standard curves. In a typical digital PCR experiment, the sample
is randomly distributed into discrete partitions, such that some
contain no nucleic acid template and others contain one or
more template copies. The partitions are thermally cycled to
end-point and then read to determine the fraction of positive
partitions, from which the concentration is calculated using
eq 1.
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where M is the average number of target molecules per
partition, P is the number of partitions containing amplified
product, and R is the number of partitions or reactions
analyzed.
6
Two key factors influence the reliability of digital PCR
measurements: the number of reactions analyzed (R) and the
number of template molecules in the assay.
7 Since concen-
tration is derived by dividing the copy number estimate by the
assay volume, an additional key factor, partition volume (Vd)
(and its associated uncertainty) needs to be considered when
measuring DNA concentration using digital PCR.
Currently, the commercially available microfluidic chamber
based digital PCR (cdPCR) formats contain up to a few
thousand individual reactions or microfluidic chambers for each
technical replicate. Using these formats, confidence in the
estimated copy number can be improved by increasing the
number of technical replicates and hence, the total number of
reactions analyzed. However, there have been practical
limitations, primarily cost, to the number of technical replicates
that can be analyzed by cdPCR. A new dPCR format called
Droplet Digital PCR (ddPCR) has recently been commercial-
ized.
8 A single ddPCR is comprised of approximately 20 000
partitioned droplets, a number which is about 25 times the 765
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In this study, we evaluated key factors that can influence the
reliability of results obtained from an early access beta-prototype
ddPCR system (Bio-Rad, Pleasanton, CA). The linearity of the
response and the precision over the dynamic range of the 20000-
droplet assay (referred to as 20000-ddPCR) were assessed. Since
the droplets are generated from a single-use eight channel droplet
generator cartridge, we examined both the intra- and inter-
cartridge repeatability of assays. Copy number concentration and
ratio together with their expanded uncertainties were assessed
using both a high density ddPCR technology and a lower density
cdPCR platform.
■ EXPERIMENTAL SECTION
Lambda DNA Solution and PCR Assays. Lambda DNA
solution (Fermentas) was analyzed using the primer and probe
sequences and concentrations for assays 2 and 5 as previously
described.
9 (Table S-1 in the Supporting Information). Assays
2 and 5 target different regions of the Lambda DNA genome
(5′ base of the amplicon is 16 541 and 44925, respectively,
in the 48502 base pair Lambda DNA genome) and pro-
duce amplicons of 188 and 76 base pair (bp), respectively.
9
The Lambda DNA was used as supplied and not physically or
enzymatically treated to reduce fragment length prior to
analysis.
Droplet Digital PCR Instrumentation, Workflow, and
Data Analysis. All experimental work including ddPCR and
droplet volume measurements was conducted at the National
Measurement Institute, Australia. Reaction mixtures of 20 μL
volume comprising 1× ddPCR Master Mix (Bio-Rad), relevant
forward and reverse primers and probe(s) (Table S-1 in the
Supporting Information), and DNA were prepared using a
gravimetric protocol to minimize the uncertainty due to
pipetting. The ddPCR reagents, except DNA, were premixed
and the final reaction mix was prepared gravimetrically by
combining the DNA and PCR components (Supporting
Information S-1). Each 20 μL reaction was dispensed into a
separate well of a disposable eight channel droplet generator
cartridge (Figure 1A; Bio-Rad). A volume of 60 μL of droplet
generation oil (Bio-Rad) was then loaded into each of the
corresponding oil wells before the consumable chip was loaded
into a beta-prototype droplet generator (Bio-Rad). The droplet
generator applies a vacuum to each of the outlet wells to
generate droplets in the eight channels simultaneously at a rate
of ∼1000 droplets/channel/second until the complete 20 μL
ddPCR mixture has been partitioned into the monodisperse
water-in-oil emulsion format. Each water-in-oil emulsion was
transferred by pipet to a separate well of a 96-well
polypropylene plate (Eppendorf), heat sealed with foil, and
amplified in a conventional calibrated thermal cycler
(Eppendorf Mastercycler ep “S” thermocycler). Thermal
cycling conditions consisted of a 10 min activation period at
Figure 1. Schematic showing the ddPCR workflow. (A) Each 20 μL sample containing the Master Mix, primers, TaqMan probes, and DNA target is
loaded in the middle wells of a disposable eight channel droplet generator cartridge (pictured). Droplet generation oil (8 × 60 μL) containing the
emulsion stabilizing surfactant is then loaded into the left-hand wells of the droplet generator cartridge. A vacuum is automatically applied to the
outlet well (right) creating a pressure difference that, together with the geometry of the microfluidic circuit, converts the aqueous sample into stable,
monodisperse, water-in-oil droplet emulsions which concentrate due to density differences from the oil phase and accumulate in the droplet
collection wells of the cartridge. The droplets from each well are then transferred to one well of a 96-well plate, foil sealed, and thermal-cycled to the
end-point. (B) After amplification, the plate is then loaded to a droplet reader where an autosampler aspirates the droplets and, using a microfluidic
singulator, streams them single file (∼1500 droplets/s) past a FAM/VIC two color fluorescence detector which samples at a rate of 100 kHz. (C)
The difference in fluorescence amplitudes for droplets where amplification has or has not occurred (positive and negatives, respectively) divides the
entire droplet population into four discrete clusters for a typical Fam/Vic duplex assay. These four populations are droplets containing either no
target (F−/V−), one of the targets (F−/V+, F+,V−), or both targets (F+,V+). Setting a fluorescence threshold for each detection channel affords a
digital method of droplet classification and computing the average number of copies per droplet based on the fraction of positive droplets and
Poisson modeling.
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15 s at 94 °C denaturation and 60 s at 60 °C for combined
annealing-extension at 100% ramp rate and a final 10 min
inactivation step at 98 °C. After thermal cycling, plates were
transferred to a beta-prototype droplet reader (Bio-Rad) that
employs an integrated autosampler and fluidics to serially
aspirate droplets from each well and stream them single-file,
at a rate of ∼1 500 droplets/second, past a two-color
fluorescence detector sampled at a rate of 100 kHz on both
FAM and VIC fluorescence channels (Figure 1B). Sampling at
100 kHz affords the ability to gate outliers on a case-by-case
basis using properties of the fluorescence trace (automated by
Bio-Rad Signal Processing Algorithm v0.43). Discrimination
between droplets that did not contain target (negatives) and
those which did (positives) was achieved by applying a global
fluorescence amplitude threshold in QuantaSoft (Bio-Rad), the
software package provided with the ddPCR system for data
acquisition and analysis. The droplet reader was calibrated once
upon installation of the ddPCR system at the National Mea-
surement Institute, Australia. The simple calibration procedure
generated an instrument-specific color compensation matrix that
was subsequently stored on the droplet reader and automatically
applied to data to eliminate cross talk between FAM and VIC
labeled probes. The QuantaSoft software had a factory preset
value for droplet volume. QuantaSoft uses a proprietary signal-
processing algorithm to automatically perform droplet gating
within each run. The threshold was set as the midpoint between
the average fluorescence amplitude of positives and negative
droplet clusters on each of the FAM and VIC channels (Figure 1C).
Droplets appeared stable through the entire process including
pipet manipulations, thermal cycling, and reading. Rejection criteria
for excluding a well from subsequent analysis during our dynamic
range studies on the prototype droplet reader included (i) a clog
detected by the Bio-Rad Signal Processing Algorithm software
of the droplet reader or (ii) a low number of droplets measured per
20 μLP C R .
Digital PCR Instrumentation and Data Analysis. Digital
PCR analysis was performed using 12.765 digital arrays
on a BioMark System (Fluidigm, South San Francisco)
(referred to as 765-cdPCR). The final reaction mix for each
digital panel comprised 1000 predicted copies of Lambda DNA,
1× ABI Taqman FAST PCR Mastermix with no UNG
AmpErase (Applied Biosystems Melbourne, Australia), 1×
sample loading reagent (Fluidigm, South San Francisco), and
relevant forward and reverse primers and probe (Table S-1 in
the Supporting Information). To minimize the uncertainty
from pipetting, all PCR components excluding DNA were pre-
mixed and then the final reaction mix was prepared
gravimetrically by combining the DNA and PCR components.
A volume of 10 μL of the reaction mix was aliquoted into each
sample inlet on the digital array with approximately 4.6 μLo f
the reaction mix distributed throughout the partitions within
each panel using an automated MX Integrated Fluidic Circuit
(IFC) Controller (Fluidigm, South San Francisco). The chip
setup was randomized. No Template Controls (NTC)
containing 1× TE0.1 buffer (10 mM Tris, 0.1 mM EDTA,
pH 8.0) in place of DNA or blank panels containing 1× TE0.1
buffer in place of DNA and primer/probes were analyzed in
one or more alternate panels. Blank panels were used in order
to accommodate the chip-setup (Figure S-1 in the Supporting
Information). Digital array thermal cycling conditions consisted
of a 2 min activation period at 95 °C, followed by 50 cycles of a
two-step thermal profile involving 10 s at 95 °C for denatura-
tion, and 30 s at 60 °C, for combined annealing and extension.
The data was analyzed using BioMark data analysis software
(v3.0.2) using a manually set quality threshold of 0.01 and target
Ct range of 15−50.
Linearity and Precision over Theoretical Dynamic
Range of ddPCR Instrument. Three independent gravi-
metric serial dilutions of Lambda DNA were prepared using a
standard protocol (Supporting Information S-1) to produce
three sets of seven solutions containing an average 26, 105, 409,
1 630, 6495, 25700, and 103 000 predicted copies of Lambda
DNA per 20 μL ddPCR based on absorbance measurements of
the stock Lambda DNA solution at 260 nm (Figure 2). For two
of the serial dilution sets (gravimetric dilution series 2 and 3),
eight replicate ddPCRs were prepared from a single eight-
channel droplet generator cartridge for each of the seven
solutions. For gravimetric dilution series 1, 24 replicate ddPCRs
were prepared from three eight-channel droplet generator
cartridges for each of the seven solutions. The ddPCRs were
analyzed using assay 2 under simplex conditions. A complete
eight channel cartridge of NTC was prepared by adding
1× TE0.1 buffer in place of DNA template. NTCs showed a
Figure 2. Schematic diagram of experimental design for assessing linearity and precision.
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droplets per NTC assay, which could possibly be attributed to
low-level template contamination during the preparation of
the reaction mixture. The data generated was used to assess
linearity and precision over the theoretical dynamic range of the
instrument in addition to intracartridge and intercartridge
ddPCR precision.
Comparison of DNA Concentration and Ratio Mea-
surements Using Two Different dPCR Formats under
Simplex and Duplex Conditions. Three independent
gravimetric serial dilutions of Lambda DNA were prepared.
For each gravimetric dilution series, one dilution was selected
for analysis using both 20 000-ddPCR and 765-cdPCR. This
dilution provided a predicted number of 1.3 copies per 6 nL
reaction (based on A260 measurement of NaOH denatured
stock Lambda DNA
9) for the microfluidic 765-cdPCR which is
close to the optimal 1.5 molecules per reaction for minimizing
the uncertainty of the copy number estimate.
10 Since the
droplet volume is approximately one-sixth of the chamber
volume, the predicted number of copies per 1 nL droplet
volume was 0.2 copies per droplet which is less than
the optimal number for this digital PCR format. For each of the
three gravimetric dilutions, five replicate ddPCR and five repli-
cate microfluidic cdPCR were prepared and analyzed. The
ddPCRs droplets were generated from one eight channel droplet
generator cartridge, and the replicates were transferred to separate
wells within a single column of a 96-well plate for thermal cycling
and droplet reading. A total of 15 NTCs containing 1× TE0.1 in
place of DNA template were similarly prepared and transferred to
three individual columns (five replicas assays each) of the 96-well
plate. NTCs showed a low-level background signal of approxi-
mately two positive droplets per NTC assay. The microfluidic
cdPCR assays were prepared and then analyzed across two 12.765
chips (randomly designated to two panels in one chip and three
panels in the other chip). Each microfluidic cdPCR experiment
contained either one or two NTC panels per chip. All NTC
panels were negative. For ddPCR and microfluidic cdPCR, the
replicate assays were analyzed using assay 2 under simplex con-
ditions. A similar experimental setup was used for analysis with
assay 5 under simplex conditions and for both assays 2 and 5
under duplex conditions.
Optical Microscope Imaging to Determine Droplet
Volume. The average droplet volume was independently
measured at the National Measurement Institute, Australia, to
compare with that quoted by the ddPCR instrument manu-
facturer (BioRad, personal communication), by measurement of
droplets generated from 16 different channels. Droplets used for
optical imaging to determine droplet volume were prepared
using the same reagents as used for ddPCR estimation of Lambda
DNA concentration. Either three or four wells were randomly
selected from each of five different droplet generator cartridges
for this analysis. Between 61 and 77 droplets were measured
from each channel providing measurement of 1122 droplets in
total.
The droplets were transferred by pipet into 1 μ-Slide VI flat
uncoated microscopy chambers (IBIDI Germany) that had
been prefilled with droplet generation oil (Bio-Rad). After
filling, the slides were gently held at an angle to allow a uniform
monolayer of droplets to develop at the upper oil−slide
interface for imaging. An optical microscope (Leica DM6000M)
with a digital CCD camera (Leica DFC490) was used to image
the droplets. Images were recorded under uniform illumination
in a bright field, using a HC PL FLUOTAR 20×/0.50 BD/
Coverglass: O/ICT upright: K2+D (K3+D1)/ICR: D1/D/
thread: M32/FWD: 1.27 objective with numerical aperture 5, to
produce images at 200× apparent magnification. A 12 V 100 W
tungsten halogen lamp was used as the illumination source.
Digital images were collected on a computer running the Leica
Application Suite Software v3.5. Images were captured in
interlaced large high-quality format, corresponding to an image
size of 3264 × 2448 pixels.
The x and y length scales of the microscope/camera system
were calibrated using a stage micrometer, model MW-1540.
Calibration values indicated the CCD comprised a square pixel
array to within the limits of relative uncertainty of the scale bar
measurement of 0.1%. The calibration was repeated by placing
one 1 μ-Slide VI filled with droplet generation oil over the
micrometer features to investigate the impact of refractive index
differences of the slide−oil interface. A change of the calibra-
tion of less than 0.1% was observed which is of the same order
as the uncertainty of the calibration.
ImageJ software v1.42
11 was used for analysis of the digital
images. Images were first converted to a bit depth of 8-bit for
processing. The edges of the droplets were identified using the
“find edges” algorithm. The image was then inverted, and
the edges of the droplets were identified by thresholding the
images. To enable detection of the full droplet, a “fill holes”
algorithm was run after noise reduction and despeckling.
The image was then thresholded again to achieve detection
of the entire droplet. The watershed algorithm implemented
in the ImageJ software was used to separate touching drop-
lets. Droplets on the edge of the image were excluded from
analysis.
The binary images of the droplets were then analyzed. The
major and minor axis of an elliptical fit to the droplet
outline were determined and used to calculate the area in
(pixels)
2 of an ellipse of equivalent dimensions. This value
was then used to determine the diameter of a circle of an
equivalent area. This equivalent circular diameter, measured
in pixels, was converted to length units by applying the
conversion factor between the length measured in pixel units
and length measured in micrometers determined from the
instrument calibration. Finally, the equivalent spherical volume
of a sphere having the equivalent circular diameter was
calculated.
The sensitivity of the droplet size to the focus was
investigated by analyzing images taken at focal planes displaced
by up to ±6 μm from ideal focus. The resulting variation of the
measured volume due to minor out of focus variation
introduced during image data collection was found to be less
than 1.4% (Figure S-2 in the Supporting Information).
Determination of Stock DNA Copy Number Concen-
tration from ddPCR and cdPCR Data. The number
of accepted droplet reactions in each ddPCR, R, was between
10 000 and 18000. The droplet copy number concentration,
Td, was calculated by multiplying M by 1000/Vd, where Vd is
the mean droplet volume (nL) (eq 2).
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The template DNA concentration in the original stock
solution, T, can then be calculated by multiplying Td by the
total dilution factor, D, used to dilute the stock DNA solution
into the final ddPCR solution (eq 3).
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To estimate the template copy number concentration using a
12.765 cdPCR chip, R was substituted with 765 in the above
equations since this is the number of chambers per panel.
Estimation of Measurement Uncertainty. Measure-
ment uncertainty was estimated using a top-down approach.
Experimental data from independent sets (such as
independent gravimetric dilutions) and replicate measure-
ments was combined using the pooled relative standard
deviation. Equations 4 and 5 were used for precision data for
M and copy number ratio, respectively, where ni is the
number of replicates in the ith data set and CNRi is the ratio
of the copy number concentration determined between
assays 5 and 2. Equation 4 captures the precision of the copy
number estimate from Poisson modeling as well as other
Type A components such as any variation in the volume of
droplets generated from different channels of the droplet
generator or in the preparation of the gravimetric dilution
series.
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The relative standard uncertainty of the precision data was
then determined by dividing the pooled relative standard
deviation by the square root of the number of data sets as
shown in eqs 6 and 7, respectively.
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The relative standard uncertainty of the droplet volume,
(uVd)/(V̅d), is a Type B uncertainty evaluation (obtained from
information such as calibration certificates and limits deduced
from personal experience
12) and was determined from the
analysis of an individual droplet image. Factors such as
the goodness of the elliptical fit, operator bias, microscope
calibration, and effect of focus were all considered in the
estimation of this uncertainty. The combined standard
uncertainty of the concentration based on the top-down
approach, u(T), was calculated by combining the precision data
(Type A uncertainty component evaluated by statistical analysis
of a series of measurements) with a Type B uncertainty
component associated with measurement of the droplet volume
using eq 8. A full assessment of bias using this prototype
instrument was not feasible. However, the dynamic range
experiment and the comparison with an independent cdPCR
system provided data to make an assessment of bias from the
measurements of M.
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The standard uncertainty of the copy number ratio based on
the top-down approach, uCNR, was equivalent to the standard
uncertainty of the precision data, uCNRprec. Since the assays were
run under duplex conditions, the uncertainty associated with
droplet volume is minimized and was not considered in this
estimation.
The expanded uncertainty was calculated by multiplying
the standard uncertainty by a coverage factor
12 which provides
a level of confidence of 95% that the true value for the
measurand falls within the expanded uncertainty. The coverage
factor varied from 2.05 to 2.18 depending on the effective
degrees of freedom which was derived from the Welch-
Satterthwaite formula
12 and was influenced by the number of
replicates and independent data sets analyzed in each
experiment.
■ RESULTS AND DISCUSSION
Dynamic Range. The theoretical dynamic range in digital
PCR is largely determined by the number of partitions that
are analyzed. A typical ddPCR contains approximately 20 000
individually partitioned droplet reactions. On the basis of
binomial approximation, 99.5% saturation of the droplets (i.e.,
100 negative droplets in a ddPCR containing 20000 droplets)
would indicate between 102000 and 110000 copies of target
DNA (95% confidence interval) in the 20000-droplet reac-
tion. This provides a theoretical dynamic range of 105 target
copies.
We examined the ddPCR response over concentrations
ranging from approximately 37 to 131 000 copies per 20 μLo f
ddPCR. This resulted in as little as 0.16% positive droplets
through to almost complete saturation (99.6% positive
droplets). The study, which included data from three
independent gravimetric dilution series, comprised a total of
168 ddPCRs. Less than 5% of these assays were excluded from
data analysis. Five assays were excluded because a clog was
detected by the droplet reader software and an additional three
assays were excluded because either no droplets or only 192
droplets were detected by the droplet reader. The average
number of droplets read for each ddPCR was 13,825 with a
standard deviation of 1,892 droplets.
The ddPCR response was linear over this dynamic range,
which covered more than 4 orders of magnitude (r2 = 0.9994;
Figure 3a). However, as previously described for cdPCR,
7 the
relative uncertainty in concentration was not constant across
the dynamic range. The stochastic effect associated with
sampling a DNA solution increases as the concentration of the
DNA solution decreases. Consequently, as the copy number
concentration of a sample decreases, the number of target
DNA molecules in replicate ddPCR assays is more variable.
This is reflected in the relative expanded uncertainty of the
estimated stock DNA concentration which was 30 and 13%
for the assays containing 37 and 142 copies, respectively, per
20 μL of ddPCR. In comparison, the relative expanded
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copies was between 4.6 and 6.0% (Figure 3b). When analyzing
low template copies, the relative expanded uncertainty of the
ddPCR system was slightly lower than the values of 30−56%
and 40−60% reported recently for a 765-cdPCR assay con-
taining either 16 or 128 copies, respectively.
3
The Lambda DNA stock concentration was estimated from
seven gravimetrically prepared dilutions of the stock solution
that covered the above range and all results agreed within their
expanded uncertainties. The highest concentration analyzed
(131000 copies per ddPCR) contained, on average, 6.5 copies
per droplet which is 30% greater than the manufacturer’s
recommended upper concentration limit of five copies per
droplet, on average (Bio-Rad, personal communication). For
this highly concentrated ddPCR data set, 99.6% of droplets
were positive. While the stock concentration estimation from
this data set was slightly lower than the average, it still agreed
within its expanded uncertainty with the other data sets (Figure 3b).
Using ANOVA analysis, there was no significant difference
(p > 0.05) in the estimated concentration of the Lambda stock
when the 20 μL of ddPCR contained between 463 and 28 900
copies (p = 0.685, 0.243, and 0.463 for the three independent
gravimetric dilutions).
Accuracy of ddPCR by Comparison with Independent
cdPCR Measurement System. Typically, accuracy of a
measurement is assessed by the closeness of agreement
between the measured value and a true quantity value or an
accepted reference value of a measurand.
12 In the absence of a
DNA reference material certified for absolute copy number
concentration, results obtained from the ddPCR system were
compared with results obtained from a 765-cdPCR platform.
Both systems provide a measurement of the absolute copy
number concentration without the need for an external
calibrant.
Lambda DNA concentrations (copies/μL) and ratios
measured using the 20000-ddPCR and 765-cdPCR formats
were compared using two assays that target different regions of
the Lambda genome (assays 2 and 5) (Table 1).
7 Regardless of
the assay used, the Lambda DNA concentration measurements
using the 20000-ddPCR and the 765-cdPCR agreed within
their expanded uncertainties, which were estimated by
multiplying the combined standard uncertainty (eq 8) with a
coverage factor between 2.05 and 2.13 to provide a level of
confidence of 95%. The relative expanded uncertainties for the
20 000-ddPCR were 3.2% and 4.2% for assay 5 and assay 2,
respectively, while for the 765-cdPCR the relative expanded
uncertainties were 13% and 15%, respectively. The combination
of a lower uncertainty in partition volume together with an
increase in the number of partitions analyzed has resulted in
a lower uncertainty for copy number concentration using
ddPCR compared to the microfluidic cdPCR even though
the concentration analyzed was most suited to minimizing
precision for the chamber microfluidic cdPCR format (see
Experimental Section, Comparison of DNA Concentration
and Ratio Measurements Using Two Different dPCR
Formats under Simplex and Duplex Conditions). For
ddPCR using assay 2, measurement precision contributed
77% of the combined total uncertainty (Figure 4b).
Approximately 9% of the Type A precision component of
the total uncertainty could be attributed to the copy number
per droplet measurement, M, which is determined using
Poisson modeling, and 3% was attributed to the gravimetric
dilution steps. The remainder could be mainly attributed to
the variation in volume of droplets generated from different
wells of the droplet generator cartridge (Figure S-3 in
the Supporting Information). The major component of the
Type B droplet volume uncertainty was the estimation of
the out-of-plane ellipsoid axis. The much larger uncertainty for
the 765-cdPCR was predominantly due to the uncertainty
associated with measurement of the z-axis of the chamber
volume using optical microscopy, as previously described,
7 and
this would also be the case if multiple panels on the higher
density microfluidic 48.770 chip (Fluidigm) were analyzed to
achieve a similar number of total reactions as for the 20 000-
ddPCR. If the z-axis could be measured using a technique
with lower uncertainty, this may reduce the uncertainty of
the chamber volume and the overall uncertainty of cdPCR
measurements using a chamber format. However, 18 panels on
the 48.770 chip would be required to obtain 13 860 partitions,
Figure 3. (a) Linearity and (b) precision across the dynamic range of
ddPCR. (a) Red, green, and blue error bars denote the standard
deviation of the Lambda DNA copy number per 20 μL of ddPCR for
each of three independent gravimetric dilutions (estimated from
n = 7 or 8 replicates in each case). The 95% confidence interval of
the slope of the combined data is as indicated in the equation. (b)
Each symbol denotes the stock Lambda DNA concentration
(copies/μL) (estimated from n = 7 or 8 replicates for each of
three independent gravimetric dilutions). Error bars represent the
expanded uncertainty calculated by multiplying the combined
standard uncertainty (eq 8) with a coverage factor of between
2.05 and 2.09 depending on the number of replicates in the
independent gravimetric dilutions. This provides a level of
confidence of 95% in the expanded uncertainty.
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cations.
When the number of reactions in digital PCR is less than one
thousand, the estimated copy number will tend to be a larger
contributor to the uncertainty than the partition volume
(Figure 4a). As the number of reactions increases, the
confidence associated with the predicted copy number and
the copy number concentration improves dramatically.
However, at some point, the reaction volume will become a
larger contributor to the uncertainty than the copy number
measurement. When this point is reached, any additional
increase in the number of reactions will only have a small
impact on reducing the total uncertainty (Figure 4a). When the
number of reactions is more than 10000, as is the case for
ddPCR, copy number measurement can be achieved with a very
high level of precision providing there are no other sources of
variability (Figure 4a). To translate this potential improvement
in precision to the concentration estimate, droplets must be
generated consistently from one assay to the next. The ddPCR
droplets are generated using an eight channel injection molded
cartridge. Significant variation in the size of droplets generated
from different wells either within or between cartridges would
b er e f l e c t e di nt h ev a r i a t i o ni nc o n c e n t r a t i o ne s t i m a t e s
following ddPCR.
To investigate the intra- and intercartridge copy number
concentration repeatability, a ddPCR was prepared from each
well in three eight channel cartridges providing a total of 24
replicate ddPCR assays. This process was undertaken for each
of the seven dilutions of the Lambda DNA which contained
an average 26, 105, 409, 1630, 6 495, 25700, and 103 000
predicted copies of Lambda DNA per 20 μL of ddPCR, based
on absorbance measurements of the stock Lambda DNA
solution at 260 nm. The eight replicate ddPCR from one
cartridge were dispensed into the wells of one column of a 96-
well plate prior to end-point PCR. For each Lambda DNA
dilution, the assays prepared from three replicate cartridges
were analyzed in adjacent columns on the same 96-well plate to
minimize possible contributions caused by intraplate variability.
ANOVA within and between the ddPCR derived from three
replicate cartridges demonstrated no significant intracartridge
effect at any of the Lambda DNA concentrations analyzed
(p-values ranging from 0.124 to 0.716). There was no significant
intercartridge effect for seven of the nine dilutions analyzed
(p-values ranging from 0.153 to 0.698), implying that any
intracartridge variability in the size of droplets generated was
similar to that of the intercartridge variability.
To verify the reproducibility of droplet volume, a sample of
1 122 droplets generated from a total of 16 wells located across
5 separate cartridges were imaged, and each droplet volume was
measured using image processing (Figure S-3 in the Supporting
Information). The mean droplet volume obtained from image
processing measurements was 0.868 nL. A Type B uncertainty
evaluation of an individual droplet volume measurement
estimated the relative expanded uncertainty of this measure-
ment as 2.0% using a coverage factor of 2.04. This measured
droplet volume and associated uncertainty agrees with the
manufacturer’s independently estimated value of 0.89 nL for
droplets generated from the eight channel droplet generator
cartridges (Bio-Rad, personal communication). The relative
standard deviation of the mean interwell droplet volume for the
16 wells was 2.8%. ANOVA demonstrated no significant
intracartridge (p = 0.801) or intercartridge (p = 0.053) effect on
the partition volume confirming that the observed variation in
droplet volume between wells was independent of the cartridge.
Provided sufficient numbers of replicate wells are analyzed, this
well-to-well variation in droplet volume is likely to be captured
within the precision data of replicate concentration measurements
(Figure 4b) and was, therefore, not considered as a separate
component in the top down uncertainty estimation.
Assuming that the Lambda DNA genome is intact, the copy
number ratio between assay 5 and assay 2 should result in a
ratio of 1.0. The Lambda DNA copy number ratio between
Table 1. Comparison of Copy Number Concentration, T, and Ratio Measurements Using Two Digital PCR Formats
a
simplex
assay assay 5 assay 2
digital PCR format 20000-ddPCR 765-cdPCR 20 000-ddPCR 765-cdPCR
measured Lambda DNA stock concentration, T, (copies/μL) (eq 3) 1.026 × 1010 1.02 × 1010 1.085 × 1010 9.8 × 109
relative standard uncertainty of all precision factors, (uMprec/M̅) (%) (eq 6) 1.2 4.3 1.7 5.7
relative standard uncertainty (type B components only) of a single droplet/
chamber volume, (uVd)/V̅d (%)
1.0 4.7 1.0 4.7
expanded uncertainty of U(T), (copies/μL) 0.033 × 1010 0.13 × 1010 0.045 × 1010 1.5 × 109
relative expanded uncertainty of U(T), (%) 3.2 13 4.2 15
duplex
assay assay 5/assay 2
digital PCR format 20000-ddPCR 765-cdPCR
copy number ratio for assay 5/assay 2 (copy/copy) 1.051 1.052
expanded uncertainty of copy number ratio (copy/copy) 0.030 0.064
relative expanded uncertainty of copy number ratio (% U) 2.8 6.1
aFor the ddPCR assays, the droplet reader counted an average 13 504 gated droplets per well (range from 12127 to 14 909 droplets per well), while
the cdPCR assays contained 765 microfluidic chambers per panel. Each value is derived from five replicate analyses for each of three independent
gravimetric dilutions. Replicates contained approximately 4000 Lambda DNA copies per 20 μL of ddPCR and approximately 1000 Lambda DNA
copies per 4.65 μL of cdPCR. The Lambda DNA stock concentration was determined under simplex conditions using both assay 5 and assay 2. The
copy number ratio between assay 5 and assay 2 was determined under duplex conditions. All precision components were captured in one factor. The
only known Type B component which was significant enough to require input was from the droplet volume measurement. The expanded
uncertainties for the concentration and ratio were determined by multiplying the combined standard uncertainty (eq 8) and the standard
uncertainty,uCNVprec, respectively, by a coverage factor between 2.05 and 2.18, which provides a level of confidence of 95%. It should be noted the
magnitude of the expanded uncertainty values for T vary with concentration.
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ddPCR and the 765-cdPCR were 1.051 and 1.052, respectively,
and the corresponding relative expanded uncertainties using a
coverage factor of 2.18 were 2.8% and 6.1%, respectively (Table 1).
The lower expanded uncertainty in copy number variation
observed using the 20000-ddPCR can largely be explained by the
more than 20-fold increase in number of partitions analyzed in
each ddPCR assay.
■ CONCLUSIONS
In this study we have demonstrated experimentally that this
ddPCR system can achieve a linear dynamic range of more
than 4 orders of magnitude for DNA quantification. The large
number of reactions in this ddPCR system allowed very precise
copy number estimates which resulted in a relative expanded
uncertainty of less than 5% for Lambda DNA copy number
concentration. Further improvements in uncertainty of absolute
copy number quantification may be achieved by increasing the
number of replicates analyzed. However, this will be limited by
the partition volume uncertainty when it becomes a larger
contributor to the uncertainty than the precision of copy
number estimates (Figure 4). For duplex copy number ratio
measurements, the contribution from partition volume in the
uncertainty estimate is minimized since both assays are con-
ducted in the same ddPCR. Therefore, increasing the number
of partitions will lead to further improvements in precision, and
this can be readily and practically achieved by combining the
results of replicate wells.
Because of the high level of precision that can be obtained
from ddPCR and other high density cdPCR formats,
13,14 it is
particularly important that the experimental design replicates
capture all known sources of variation, and that components of
bias are identified and included in the uncertainty budget to
ensure the measurements are also accurate.
15 For the prototype
instrument used in this study, it was difficult to make a full
assessment of bias. However, dynamic range studies did not
indicate a concentration-dependent bias, and concentration
measurements were comparable with results obtained using an
independent microfluidic cdPCR. This ddPCR technology
should be fit-for-purpose for a wide range of applications, including
the direct quantification of nucleic acids for gene expression (e.g.,
miRNAs), pathogen quantification, rare allele detection, germline
and somatic copy number variation estimation, some of which
have recently been demonstrated.
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Figure 4. Factors contributing to measurement uncertainty. (a) Theoretical relative expanded uncertainty of concentration considering only two
factors: Type B partition volume component, Vd with a relative uncertainty of 1.0% (green), and uncertainty of the Poisson modeling of copy
number per droplet, M,
7 (mesh blue) calculated for the condition when 80% of the reactions are positive following digital PCR. This is close to the
optimal percentage of positive reactions for minimizing the uncertainty of the copy number estimate, regardless of the number of reactions in the
assay.
10 The relative standard uncertainties of these two factors were combined (inset) and then multiplied by two to obtain the relative expanded
uncertainty with a level of confidence of 95%. (b) Contributions to concentration uncertainty for a ddPCR data set comprising five replicate analyses
from each of three independent gravimetric dilutions analyzed using assay 2 under simplex conditions (see Table 1 for details). This data set had a
relative expanded uncertainty of only 4.2%, which was determined by multiplying the combined standard uncertainty (eq 8) by a coverage factor of
2.09 to provide a level of confidence of 95%. The contributions of the components of droplet volume (Type B components only) are indicated in
green shading and the components of precision are indicated in blue shading. In this data set, a total of 190 433 droplets were accepted by the
droplet reader and 19.1% of these droplets were positive.
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